BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24503810)

  • 21. Specific immunologic recognition of the tumor-specific E2A-PBX1 fusion-point antigen in t(1;19)-positive pre-B cells.
    Berendes P; Hoogeveen A; van Dijk M; van Denderen J; van Ewijk W
    Leukemia; 1995 Aug; 9(8):1321-7. PubMed ID: 7643619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrovirus-Mediated Expression of E2A-PBX1 Blocks Lymphoid Fate but Permits Retention of Myeloid Potential in Early Hematopoietic Progenitors.
    Woodcroft MW; Nanan K; Thompson P; Tyryshkin K; Smith SP; Slany RK; LeBrun DP
    PLoS One; 2015; 10(6):e0130495. PubMed ID: 26098938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical role for a single leucine residue in leukemia induction by E2A-PBX1.
    Bayly R; Murase T; Hyndman BD; Savage R; Nurmohamed S; Munro K; Casselman R; Smith SP; LeBrun DP
    Mol Cell Biol; 2006 Sep; 26(17):6442-52. PubMed ID: 16914730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice.
    Kamps MP; Baltimore D
    Mol Cell Biol; 1993 Jan; 13(1):351-7. PubMed ID: 8093327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oligomeric self-association contributes to E2A-PBX1-mediated oncogenesis.
    Lin CH; Wang Z; Duque-Afonso J; Wong SH; Demeter J; Loktev AV; Somervaille TCP; Jackson PK; Cleary ML
    Sci Rep; 2019 Mar; 9(1):4915. PubMed ID: 30894657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
    Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
    Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pbx1 is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B-cell acute lymphoblastoid leukemia.
    Van Dijk MA; Voorhoeve PM; Murre C
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6061-5. PubMed ID: 8327485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice.
    Sykes DB; Kamps MP
    Mol Cell Biol; 2004 Feb; 24(3):1256-69. PubMed ID: 14729970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1.
    Knoepfler PS; Calvo KR; Chen H; Antonarakis SE; Kamps MP
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14553-8. PubMed ID: 9405651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes.
    Lu Q; Knoepfler PS; Scheele J; Wright DD; Kamps MP
    Mol Cell Biol; 1995 Jul; 15(7):3786-95. PubMed ID: 7791786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fusion with E2A alters the transcriptional properties of the homeodomain protein PBX1 in t(1;19) leukemias.
    LeBrun DP; Cleary ML
    Oncogene; 1994 Jun; 9(6):1641-7. PubMed ID: 8183558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein kinase A-dependent transactivation by the E2A-Pbx1 fusion protein.
    Ogo A; Waterman MR; Kamps MP; Kagawa N
    J Biol Chem; 1995 Oct; 270(43):25340-3. PubMed ID: 7592695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting interactome network perturbations in human cancer: application to gene fusions in acute lymphoblastic leukemia.
    Hajingabo LJ; Daakour S; Martin M; Grausenburger R; Panzer-Grümayer R; Dequiedt F; Simonis N; Twizere JC
    Mol Biol Cell; 2014 Dec; 25(24):3973-85. PubMed ID: 25273558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia.
    Wiemels JL; Leonard BC; Wang Y; Segal MR; Hunger SP; Smith MT; Crouse V; Ma X; Buffler PA; Pine SR
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15101-6. PubMed ID: 12415113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of cooperative genes for E2A-PBX1 to develop acute lymphoblastic leukemia.
    Sera Y; Yamasaki N; Oda H; Nagamachi A; Wolff L; Inukai T; Inaba T; Honda H
    Cancer Sci; 2016 Jul; 107(7):890-8. PubMed ID: 27088431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1.
    Fu X; McGrath S; Pasillas M; Nakazawa S; Kamps MP
    Oncogene; 1999 Sep; 18(35):4920-9. PubMed ID: 10490826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hoxa9 collaborates with E2A-PBX1 in mouse B cell leukemia in association with Flt3 activation and decrease of B cell gene expression.
    Hassawi M; Shestakova EA; Fournier M; Lebert-Ghali CÉ; Vaisson G; Frison H; Sinnett D; Vidal R; Thompson A; Bijl JJ
    Dev Dyn; 2014 Jan; 243(1):145-58. PubMed ID: 23996689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural basis of CBP/p300 recruitment in leukemia induction by E2A-PBX1.
    Denis CM; Chitayat S; Plevin MJ; Wang F; Thompson P; Liu S; Spencer HL; Ikura M; LeBrun DP; Smith SP
    Blood; 2012 Nov; 120(19):3968-77. PubMed ID: 22972988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E2A-PBX1 Remodels Oncogenic Signaling Networks in B-cell Precursor Acute Lymphoid Leukemia.
    Duque-Afonso J; Lin CH; Han K; Wei MC; Feng J; Kurzer JH; Schneidawind C; Wong SH; Bassik MC; Cleary ML
    Cancer Res; 2016 Dec; 76(23):6937-6949. PubMed ID: 27758892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1.
    de Lau WB; Hurenkamp J; Berendes P; Touw IP; Clevers HC; van Dijk MA
    Oncogene; 1998 Jul; 17(4):503-10. PubMed ID: 9696044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.